tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

CELC Stock Latest News

Celcuity Inc.’s Promising Phase 3 Breast Cancer Study: A Market Game-Changer?
Company AnnouncementsCelcuity Inc.’s Promising Phase 3 Breast Cancer Study: A Market Game-Changer?
2d ago
CELC
Celcuity’s Phase 3 Breast Cancer Study: A Potential Game-Changer?
PremiumCompany Announcements
Celcuity’s Phase 3 Breast Cancer Study: A Potential Game-Changer?
2d ago
CELC
Celcuity Inc.’s Promising Study on mCRPC Treatment: Key Insights for Investors
PremiumCompany Announcements
Celcuity Inc.’s Promising Study on mCRPC Treatment: Key Insights for Investors
2d ago
CELC
Celcuity price target raised to $77 from $66 at H.C. Wainwright
PremiumThe Fly
Celcuity price target raised to $77 from $66 at H.C. Wainwright
8d ago
CELC
Celcuity Announces Promising Phase 3 Trial Results
PremiumCompany Announcements
Celcuity Announces Promising Phase 3 Trial Results
9d ago
8K
CELC
Celcuity rises 46.3%
PremiumThe FlyCelcuity rises 46.3%
10d ago
CELC
Celcuity price target raised to $95 from $70 at Needham
Premium
The Fly
Celcuity price target raised to $95 from $70 at Needham
10d ago
CELC
CHRO
Celcuity rises 47.7%
Premium
The Fly
Celcuity rises 47.7%
10d ago
CELC
Morning Movers: Cleveland-Cliffs surges following earnings report
PremiumThe Fly
Morning Movers: Cleveland-Cliffs surges following earnings report
10d ago
CLF
COO
Celcuity provides update on status of PIK3CA mutant cohort
PremiumThe Fly
Celcuity provides update on status of PIK3CA mutant cohort
10d ago
CELC
Celcuity presents updated data at 2025 ESMO for Phase 1 study of gedatolisib
PremiumThe Fly
Celcuity presents updated data at 2025 ESMO for Phase 1 study of gedatolisib
10d ago
CELC
Celcuity announces results from PIK3CA wild-type cohort of Phase 3 VIKTORIA-1
PremiumThe Fly
Celcuity announces results from PIK3CA wild-type cohort of Phase 3 VIKTORIA-1
10d ago
CELC
Optimistic Buy Rating for Celcuity Amid Anticipated PIK3CA Mutant Cohort Results in VIKTORIA-1 Study
PremiumRatingsOptimistic Buy Rating for Celcuity Amid Anticipated PIK3CA Mutant Cohort Results in VIKTORIA-1 Study
27d ago
CELC
Guggenheim starts Celcuity with Buy on breast cancer potential
Premium
The Fly
Guggenheim starts Celcuity with Buy on breast cancer potential
1M ago
CELC
Celcuity initiated with a Buy at Guggenheim
Premium
The Fly
Celcuity initiated with a Buy at Guggenheim
1M ago
CELC
Short Report: Celcuity short interest at two-year high
PremiumThe Fly
Short Report: Celcuity short interest at two-year high
2M ago
AEVA
CELC
Celcuity’s Enhanced Financial Flexibility and Strategic Progress Justify Buy Rating
PremiumRatings
Celcuity’s Enhanced Financial Flexibility and Strategic Progress Justify Buy Rating
2M ago
CELC
Celcuity Expands Credit Facility to $500 Million
PremiumCompany Announcements
Celcuity Expands Credit Facility to $500 Million
2M ago
8K
CELC
Celcuity Inc. Earnings Call: Clinical Progress and Financial Fortification
PremiumCompany Announcements
Celcuity Inc. Earnings Call: Clinical Progress and Financial Fortification
2M ago
CELC
Celcuity’s Gedatolisib Gains Momentum with FDA’s RTOR Program and Promising Phase 3 Trial Results
PremiumRatingsCelcuity’s Gedatolisib Gains Momentum with FDA’s RTOR Program and Promising Phase 3 Trial Results
2M ago
CELC
Celcuity to initiate gedatolisib NDA submission
Premium
The Fly
Celcuity to initiate gedatolisib NDA submission
2M ago
CELC
Celcuity price target raised to $66 from $50 at H.C. Wainwright
Premium
The Fly
Celcuity price target raised to $66 from $50 at H.C. Wainwright
2M ago
CELC

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >